Clinical Trial Update: A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating systemic chemotherapy CPT-11 with hepatic arterial infusion FUDR+L-OHP for initially unresectable colorectal cancer with liver metastas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• CPT-11 (irinotecan) (irinotecan)
• FUDR (floxuridine)
• L-OHP

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colo-rectal Cancer, Liver Metastases | Phase 2 | Status: COMPLETED